McLaughlin JR - Search Results

1

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. McLaughlin JR, et al. Lancet Oncol. 2007 Jan;8(1):26-34. doi: 10.1016/S1470-2045(06)70983-4. Lancet Oncol. 2007. PMID: 17196508

2

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ. Zweemer RP, et al. Among authors: mclaughlin jr. J Clin Pathol. 1999 May;52(5):372-5. doi: 10.1136/jcp.52.5.372. J Clin Pathol. 1999. PMID: 10560359 Free PMC article.

3

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA. Risch HA, et al. Among authors: mclaughlin jr. Am J Hum Genet. 2001 Mar;68(3):700-10. doi: 10.1086/318787. Epub 2001 Feb 15. Am J Hum Genet. 2001. PMID: 11179017 Free PMC article.

4

A genetic epidemiological study of carcinoma of the fallopian tube.

Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J, Narod SA. Aziz S, et al. Gynecol Oncol. 2001 Mar;80(3):341-5. doi: 10.1006/gyno.2000.6095. Gynecol Oncol. 2001. PMID: 11263928

5

Histopathologic features of genetically determined ovarian cancer.

Shaw PA, McLaughlin JR, Zweemer RP, Narod SA, Risch H, Verheijen RH, Ryan A, Menko FH, Kenemans P, Jacobs IJ. Shaw PA, et al. Among authors: mclaughlin jr. Int J Gynecol Pathol. 2002 Oct;21(4):407-11. doi: 10.1097/00004347-200210000-00011. Int J Gynecol Pathol. 2002. PMID: 12352190

6

The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer.

Fung WL, Risch H, McLaughlin J, Rosen B, Cole D, Vesprini D, Narod SA. Fung WL, et al. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):678-80. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12869412

7

Prophylactic oophorectomy in Ontario.

Elit L, Rosen B, Goel V, McLaughlin J, Fung MK, Shime J, Narod S. Elit L, et al. Fam Cancer. 2001;1(3-4):143-8. doi: 10.1023/a:1021174604905. Fam Cancer. 2001. PMID: 14574170

8

Ratio of female to male offspring of women tested for BRCA1 and BRCA2 mutations.

Kotar K, Brunet JS, Møller P, Hugel L, Warner E, McLaughlin J, Wong N, Narod SA, Foulkes WD. Kotar K, et al. J Med Genet. 2004 Aug;41(8):e103. doi: 10.1136/jmg.2004.019687. J Med Genet. 2004. PMID: 15286163 Free PMC article. No abstract available.

9

Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.

Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O'Malley F, Andrulis IL, Goodwin PJ. Figueiredo JC, et al. Among authors: mclaughlin jr. Breast Cancer Res Treat. 2007 Sep;105(1):69-80. doi: 10.1007/s10549-006-9433-3. Epub 2006 Nov 18. Breast Cancer Res Treat. 2007. PMID: 17115108

10

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA. Risch HA, et al. Among authors: mclaughlin jr. J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706. doi: 10.1093/jnci/djj465. J Natl Cancer Inst. 2006. PMID: 17148771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page